Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BriaCell Therapeutics Corp. BCTXW

Full chart Compare
Set alert

Price alert · BCTXW

All alert types
0.00 USD 0.00 (-57.14%)

Feb 26, 2026, 3:49 PM EST

0.0006 Day range 0.0019
0.0006 52-week range 0.0019
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-17.81 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -1.7×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×FY 2026: -0.0×
FY 2017 5y median -0.0× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/FCF -0.0×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×FY 2026: -0.0×
FY 2017 5y median -0.0× FY 2026
EV/EBITDA 0.0×
FY 2017: 0.3×FY 2018: -0.1×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 8.2×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.4×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -638127.4%
FY 2017: -482467.7%FY 2018: -911601.9%FY 2019: -675266.9%FY 2020: -161473.2%FY 2021: -28828.3%FY 2022: -27977.6%FY 2023: -60806.3%FY 2024: -114488305.7%FY 2025: -171154.3%FY 2026: -638127.4%
FY 2017 5y median -171154.3% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -224.3%
FY 2017: -276.4%FY 2018: 86.5%FY 2019: -87.5%FY 2020: -38.5%FY 2021: -10.5%FY 2022: -112.1%FY 2023: 537.5%FY 2024: 198.0%FY 2025: -148.4%FY 2026: -224.3%
FY 2017 5y median -112.1% FY 2026
ROIC 0.0%
FY 2017: -429.0%FY 2018: -177.8%FY 2019: 1888.5%FY 2020: 178.1%FY 2021: -12.1%FY 2022: -36.7%FY 2023: -92.6%FY 2024: 2064.8%FY 2025: -155.0%FY 2026: 0.0%
FY 2017 5y median -36.7% FY 2026
ROA -148.0%
FY 2017: -157.9%FY 2018: 46.6%FY 2019: 145.1%FY 2020: 289.6%FY 2021: -5.0%FY 2022: -27.2%FY 2023: -74.7%FY 2024: -80.3%FY 2025: -122.3%FY 2026: -148.0%
FY 2017 5y median -80.3% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 100.0%
FY 2017: -47.8%FY 2018: -54.6%FY 2019: -25.6%FY 2020: 15.6%FY 2021: -32.2%FY 2022: -119.3%FY 2023: -54.8%FY 2024: -38.6%FY 2025: 16.5%FY 2026: 100.0%
FY 2017 FY 2026
EPS (diluted) 88.9%
FY 2017: 0.9%FY 2018: -33.3%FY 2019: 16.3%FY 2020: 31.0%FY 2021: 54.9%FY 2022: 99.6%FY 2023: -11361.3%FY 2024: 78.3%FY 2025: -45.6%FY 2026: 88.9%
FY 2017 FY 2026
Free Cash Flow -2.2%
FY 2017: -28.0%FY 2018: -147.9%FY 2019: -1.8%FY 2020: 70.1%FY 2021: -568.4%FY 2022: -61.1%FY 2023: -90.2%FY 2024: -3.5%FY 2025: -14.6%FY 2026: -2.2%
FY 2017 FY 2026

Financial Health

Current Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.8×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 104×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Quick Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.8×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 103×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.9×FY 2019: -0.4×FY 2020: -0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.0×
FY 2017: 0.3×FY 2018: -0.1×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 8.2×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.4×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 0.0×
FY 2017: -624×FY 2018: -318×FY 2019: -263×FY 2020: -146×FY 2021: -151×FY 2022: -15617×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -736×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-07-31